Navigation Links
Bioartificial kidney under study at MCG

nal.

The trial now underway is looking at the efficacy of the device over 72 hours, although researchers say that if the device is eventually approved by the Food and Drug Administration, it likely would be used as long as the patient is in failure.

Kidneys require a lot of oxygen and energy to perform their endless task, which makes them easy targets in the ICU, Dr. Szerlip explains. As examples, kidneys can become ischemic and begin to fail if blood pressure drops because of a long surgery with significant blood loss. Infection can further reduce blood flow to the kidneys. Ironically, some antibiotics patients need for these infections also can harm the kidneys. Even the contrast medium needed to study kidney function can be toxic. "I have seen healthy people on antibiotics for urinary tract infections develop renal failure; that's not uncommon, but it's most dreaded in the critically ill patient," Dr. Szerlip says.


'"/>

Source:Medical College of Georgia


Page: 1 2 3

Related biology news :

1. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
2. NASA links nanobacteria to kidney stones and other diseases
3. New type of rejection blocker protects kidneys after transplant
4. New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease
5. Scientists discover that widely available drug also helps fight kidney disease
6. Gene discovery may shed light on kidney disease
7. U of M study examines kidney stone prevention in astronauts
8. Scientists solve 30-year-old mystery of mutant mouses kidney woes
9. More kidney cancer is detected and treated early, yet death rate rises
10. Key gene controlling kidney development found
11. Mutant gene causes severe kidney disease in infants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bioartificial kidney under study MCG

(Date:11/4/2009)...wire/ -- Global Rainmakers, Inc., an intellectual ...ratory, today announced that the company has exite...ommercialize its suite of technologies designed to...s. ,, During the past four years, the company h...d deploy a series of core--but expandable--technol...
(Date:11/4/2009)...re/ -- Glencoe Software, Inc., the commercial arm ...m ( http://openmicroscopy.org ), is proud to ann...of Cell Biology,s exciting new project titled "The...d a $2.5M stimulus grant through the National Inst...am, as part of the American Reinvestment and Recov...
(Date:11/3/2009)...timate loner of the ocean, cruising thousands of m... has discovered that the sharks have maintained su...s of thousands of years the white sharks in the no... into a population genetically distinct from shark...large, highly mobile species," said Salvador Jorge...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 1Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 2Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 3Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 4Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 5Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 6Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 7Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 8Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 9Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 1Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 2Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 3Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 4Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 5Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 6Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 7Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 8Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 9Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 10Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 11Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 12Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 1Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 2Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 3
..., Proteins found in sperm are central to understa...ine new diagnostic methods and fertility treatment...olecular and Cellular Proteomics (MCP). The artic...ield focusing on the function of proteins in a cel...ping identify which proteins in sperm cells are dy...
..., Technology that could reduce the environmental ...that can be used to help map out oil deposits, imp... the use of illegal steroids in athletes have scoo...led by academics in the Faculty of Engineering at ...es at The Engineer Technology and Innovation Award...
..., NEW YORK (October 8, 2008) The son...study by the Wildlife Conservation Society (WCS), ...habitat for a variety of migratory songbirds, part... The study, which appears in the October 2008 issu...t , says that through dam building, beavers create...
Other Biology News:Proteins in sperm unlock understanding of male infertility says new study 2University success at national engineering awards 2University success at national engineering awards 3Beavers: Dam good for songbirds 2
(Date:11/6/2009)...UINCY, Mass., Nov. 6 Myriant Techn... developer and manufacturer of renewable bio-chem...ed technology provider Uhde GmbH, one of the world...), announced an alliance for the engineering, proc...ased Succinic Acid plants based on renewable feeds...
(Date:11/6/2009)...ALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics... or the "Company") today announced updated results...in patients with sarcomas metastatic to the lung i...ive Tissue Oncology Society Meeting held in Miami ...er presentation, entitled "A Phase II Study of Int...
(Date:11/5/2009)...AITHERSBURG, Md., Nov. 5 ... financial results for the third quarter ended Sep...6 million ($0.04 per share) for the three months e...$6.8 million ($0.08 per share) in the comparable q...r 30, 2009, GenVec,s net loss was $14.1 million ($...
(Date:11/5/2009)...ANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCal...ing supplier of innovative products for processing...lts for the first quarter of fiscal 2010. ,, Fo...y reported revenues of $5.2 million, a 15 percent ...t quarter a year ago. The Company said the key con...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...d DURHAM, N.C., Jan. 27 As farmers,look to get mo...onsanto,(NYSE: MON ) is exploring unique ways to...h the seed. Monsanto,s new collaboration with Gras...hat by expanding the benefits of,Monsanto,s resear..., Today, Monsanto announced that it has establ...
..., Canada, Jan. 27 InNexus Biotechnology Inc. (OTC...www.ixsbio.com ), announced today that it has comp... and conditions as the private placement that was ...ment, totaled $2,207,000 of 10% unsecured converti...e into common shares of InNexus at the rate of one...
...am of scientists at the U.S. Department of Energy,...ration with researchers from the University of Del...catalyst that could make ethanol-powered fuel cell... two crucial, and previously unreachable steps nee... fuel cell reactions. Their results are published ...
Other Biology Technology:New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 3New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 4InNexus Completes Previously Announced Private Placement 2New catalyst paves the path for ethanol-powered fuel cells 2
dNTP Set from Invitrogen
StrepMAB-Immo coated microplate; 96 well from IBA GmbH
cAMP[125I] Direct SPA Screening Biotrak Assay from GE Healthcare, formerly Amersham Biosciences
GIBCO Leibovitz's L-15 Medium powder from Invitrogen
Biology Products: